AstraZeneca V. EC — The Advocate General's Opinion

Law360, New York (May 31, 2012, 1:19 PM EDT) -- On May 15, 2012, the advocate general of the EU Court of Justice issued his opinion on the appeal of the General Court's judgment in AstraZeneca v. European Commission.[1] The advocate general largely agreed with the reasoning and holdings of the General Court, and recommended that the Court of Justice reject all appeals, including AstraZeneca's appeal challenging the General Court's analysis of the definition of the relevant market and the findings that certain IP/regulatory strategies pursued by AstraZeneca related to its product Losec constituted an abuse of a dominant position in violation of Article 102 TFEU.  ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!